City Therapeutics Inc.
CTY | NASDAQ
$20.90
+$0.19 (+0.92%)
Nov 2, 2026, 12:33 PM ET · Market open
TTM Period Ending | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 | Q4 2019 Dec 31, 2019 | Q3 2019 Sep 30, 2019 | Q2 2019 Jun 30, 2019 | Q1 2019 Mar 31, 2019 | Q4 2018 Dec 31, 2018 | Q3 2018 Sep 30, 2018 | Q2 2018 Jun 30, 2018 | Q1 2018 Mar 31, 2018 | Q4 2017 Dec 31, 2017 | Q3 2017 Sep 30, 2017 | Q2 2017 Jun 30, 2017 | Q1 2017 Mar 31, 2017 | Q4 2016 Dec 31, 2016 | Q3 2016 Sep 30, 2016 | Q2 2016 Jun 30, 2016 | Q1 2016 Mar 31, 2016 | Q4 2015 Dec 31, 2015 | Q3 2015 Sep 30, 2015 | Q2 2015 Jun 30, 2015 | Q1 2015 Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 1.8B | 1.84B | 1.83B | 1.85B | 1.82B | 1.77B | 1.67B | 2.11B | 1.92B | 1.76B | 1.66B | 1.05B | 1.04B | 1.06B | 1.09B | 1.17B | 1.18B | 1.13B | 1.07B | 969M | 946M | 964M |
Depreciation & Amortization | 1.35B | 1.36B | 1.36B | 1.37B | 1.39B | 1.41B | 1.44B | 1.48B | 1.52B | 1.55B | 1.58B | 1.6B | 1.63B | 1.65B | 1.68B | 1.72B | 1.76B | 1.8B | 1.84B | 1.88B | 1.91B | 1.94B |
Stock-Based Compensation | 26M | 26M | 26M | 24M | 24M | 24M | 24M | 27M | 27M | 27M | 27M | 22M | 22M | 22M | 22M | 21M | 21M | 21M | 21M | 21M | 21M | 21M |
Other Working Capital | -3.13B | -1.57B | -911M | -414M | -1.03B | -831M | -788M | -789M | -742M | -1.72B | -2.52B | -3.18B | -3.56B | -3.99B | -3.52B | -3.25B | -2.86B | -1.81B | -1.55B | -1.14B | -1.16B | -2.37B |
Other Non-Cash Items | 1.6B | 944M | 712M | -456M | 742M | 704M | 712M | -966M | -2.19B | -2.4B | -2.27B | -759M | -684M | 132M | 13M | 40M | 419M | -191M | -127M | -267M | -1.28B | -1.04B |
Deferred Income Tax | -146M | -122M | -100M | 57M | 13M | -56M | -48M | 671M | 714M | 782M | 773M | 164M | 151M | 137M | 123M | -1M | 44M | 114M | 189M | 210M | 228M | 234M |
Change in Working Capital | -1.31B | -662M | -497M | 612M | -445M | -43M | 1M | -47M | 976M | 802M | 663M | 380M | 431M | -474M | -270M | -388M | -804M | -262M | -405M | 22M | 957M | 597M |
Operating Cash Flow | 3.31B | 3.39B | 3.33B | 3.46B | 3.55B | 3.81B | 3.79B | 3.27B | 2.97B | 2.52B | 2.44B | 2.46B | 2.59B | 2.53B | 2.65B | 2.56B | 2.62B | 2.61B | 2.59B | 2.83B | 2.78B | 2.71B |
Capital Expenditures | -1.14B | -1.08B | -1.06B | -1.09B | -1.05B | -1.04B | -1.04B | -974M | -1.14B | -1.3B | -1.33B | -1.49B | -1.41B | -1.31B | -1.26B | -1.21B | -1.23B | -1.26B | -1.25B | -1.27B | -1.23B | -1.2B |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 973M | 566M | -668M | -910M | 255M | -92M | -113M | 196M | -822M | -174M | -108M | 165M | 14M | 281M | -75M | 419M | 387M | -111M | 27M | -90M | -615M | -65M |
Investing Cash Flow | -171M | -518M | -1.72B | -2B | -792M | -1.13B | -1.15B | -778M | -1.97B | -1.48B | -1.44B | -1.32B | -1.39B | -1.03B | -1.33B | -789M | -842M | -1.37B | -1.22B | -1.36B | -1.84B | -1.26B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -1M | -2M | -2M | -1M | -8M | -5M | -3M | -6M | 11M | -1M | -2M | -7M | -19M | -5M | -1M | -1M | -1M | -3M | -9M | -2M | -3M |
Dividend Paid | -1.83B | -1.75B | -1.6B | -1.45B | -1.4B | -1.33B | -1.28B | -1.13B | -975M | -1.05B | -1B | -1.15B | -1.2B | -1.25B | -1.3B | -1.35B | -1.75B | -1.35B | -1.35B | -1.25B | -800M | -1.4B |
Other Financial Acitivies | -1.32B | -1.12B | -12M | -14M | -1.36B | -1.36B | -1.36B | -1.37B | -22M | -6M | -3M | 10M | 9M | -240M | -16M | -424M | -31M | 106M | -24M | -225M | -141M | -51M |
Financial Cash Flow | -3.14B | -2.87B | -1.61B | -1.46B | -2.76B | -2.68B | -2.63B | -2.49B | -997M | -1.06B | -1B | -1.14B | -1.19B | -1.49B | -1.32B | -1.77B | -1.78B | -1.24B | -1.37B | -1.48B | -941M | -1.45B |
Net Cash Flow | -4M | 2M | 2M | 3M | 2M | 4M | 5M | 2M | 5M | -12M | -4M | -3M | 2M | 14M | 2M | -2M | -2M | -2M | -3M | -11M | -18M | -17M |
Free Cash Flow | 2.17B | 2.3B | 2.28B | 2.37B | 2.5B | 2.78B | 2.75B | 2.3B | 1.82B | 1.22B | 1.11B | 972M | 1.18B | 1.22B | 1.39B | 1.35B | 1.39B | 1.35B | 1.34B | 1.57B | 1.55B | 1.51B |
Adj. Free Cash Flow | 2.14B | 2.28B | 2.25B | 2.35B | 2.47B | 2.75B | 2.73B | 2.27B | 1.8B | 1.19B | 1.08B | 950M | 1.16B | 1.2B | 1.37B | 1.33B | 1.37B | 1.33B | 1.32B | 1.55B | 1.53B | 1.49B |
Maintenance CapEx | -1.14B | -1.08B | -1.06B | -1.09B | -1.04B | -1.03B | -1.03B | -967.13M | -1.14B | -1.3B | -1.33B | -1.49B | -1.41B | -1.31B | -1.23B | -1.17B | -1.14B | -1.17B | -1.18B | -1.2B | -1.2B | -1.18B |
Growth CapEx | n/a | n/a | n/a | n/a | -6.87M | -6.87M | -6.87M | -6.87M | n/a | n/a | n/a | n/a | n/a | -713.41K | -26.4M | -34.8M | -84.68M | -92.94M | -70.62M | -68.72M | -22.92M | -16.8M |
Owner Earnings | 2.17B | 2.3B | 2.28B | 2.37B | 2.5B | 2.78B | 2.76B | 2.3B | 1.82B | 1.22B | 1.11B | 972M | 1.18B | 1.22B | 1.42B | 1.39B | 1.48B | 1.45B | 1.41B | 1.64B | 1.57B | 1.53B |
Add to Watchlist
Select watchlists to add or remove CTY